Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Phase 1 Completed 36 enrolled Sandoz

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the relative bioavailability of Bicalutamide 50 mg tablet and Casodex following a 50 mg dose in healthy subjects under fasting conditions.

Timeline

Start: 2006-08
Primary completion: 2006-08
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Bicalutamide	Other / unclassified	50 mg	—

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Summary

Timeline

Drugs

Indications